Pharma Equity Group A/S Cl A (PEG) - Cash Flow Conversion Efficiency

Latest as of December 2024: -0.136x

Based on the latest financial reports, Pharma Equity Group A/S Cl A (PEG) has a cash flow conversion efficiency ratio of -0.136x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-6.66 Million ≈ $-1.04 Million USD) by net assets (Dkr48.88 Million ≈ $7.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Pharma Equity Group A/S Cl A - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Pharma Equity Group A/S Cl A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read PEG current and long-term liabilities for a breakdown of total debt and financial obligations.

Pharma Equity Group A/S Cl A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharma Equity Group A/S Cl A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Landmarks Bhd KLSE:1643	-0.010x
DAVIDsTEA Inc F:DAT	-0.114x
Noble Mineral Exploration Inc V:NOB	-0.094x
Botala Energy Ltd AU:BTE	-0.032x
Envoy Medical Inc. NASDAQ:COCH	0.575x
Guardforce AI Co Ltd NASDAQ:GFAI	-0.017x
Tomypak Holdings Bhd KLSE:7285	-0.069x
ADTIGER CORP.LTD.DL-0005 F:55U	N/A

Annual Cash Flow Conversion Efficiency for Pharma Equity Group A/S Cl A (2009–2025)

The table below shows the annual cash flow conversion efficiency of Pharma Equity Group A/S Cl A from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see PEG stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-09-30	Dkr25.47 Million ≈ $3.99 Million	Dkr-17.66 Million ≈ $-2.76 Million	-0.693x	-48.23%
2024-09-30	Dkr48.88 Million ≈ $7.65 Million	Dkr-22.86 Million ≈ $-3.58 Million	-0.468x	+28.72%
2023-09-30	Dkr25.33 Million ≈ $3.96 Million	Dkr-16.62 Million ≈ $-2.60 Million	-0.656x	-951.34%
2022-09-30	Dkr46.05 Million ≈ $7.20 Million	Dkr-2.87 Million ≈ $-449.66K	-0.062x	-27.18%
2021-09-30	Dkr42.57 Million ≈ $6.66 Million	Dkr-2.09 Million ≈ $-326.84K	-0.049x	+83.01%
2020-09-30	Dkr34.28 Million ≈ $5.36 Million	Dkr-9.90 Million ≈ $-1.55 Million	-0.289x	-6981.66%
2019-09-30	Dkr67.16 Million ≈ $10.51 Million	Dkr-274.00K ≈ $-42.87K	-0.004x	+79.96%
2018-09-30	Dkr77.57 Million ≈ $12.14 Million	Dkr-1.58 Million ≈ $-247.05K	-0.020x	+64.80%
2017-09-30	Dkr85.09 Million ≈ $13.31 Million	Dkr-4.92 Million ≈ $-769.93K	-0.058x	-2992.17%
2016-09-30	Dkr96.78 Million ≈ $15.14 Million	Dkr-181.00K ≈ $-28.32K	-0.002x	+93.66%
2015-09-30	Dkr99.53 Million ≈ $15.57 Million	Dkr-2.94 Million ≈ $-459.67K	-0.030x	+39.77%
2014-09-30	Dkr97.95 Million ≈ $15.32 Million	Dkr-4.80 Million ≈ $-750.99K	-0.049x	-189.26%
2013-09-30	Dkr-105.44 Million ≈ $-16.50 Million	Dkr-5.79 Million ≈ $-905.73K	0.055x	+118.92%
2012-09-30	Dkr36.39 Million ≈ $5.69 Million	Dkr-10.56 Million ≈ $-1.65 Million	-0.290x	-304.66%
2011-09-30	Dkr79.67 Million ≈ $12.46 Million	Dkr-5.71 Million ≈ $-893.84K	-0.072x	+78.56%
2010-09-30	Dkr53.06 Million ≈ $8.30 Million	Dkr-17.75 Million ≈ $-2.78 Million	-0.334x	-2303.51%
2009-09-30	Dkr53.47 Million ≈ $8.37 Million	Dkr-744.00K ≈ $-116.40K	-0.014x	--

About Pharma Equity Group A/S Cl A

CO:PEG Denmark Biotechnology

Market Cap

$15.17 Million

Dkr96.98 Million DKK

Market Cap Rank

#25958 Global

#118 in Denmark

Share Price

Dkr0.08

Change (1 day)

+1.80%

52-Week Range

Dkr0.07 - Dkr0.15

All Time High

Dkr2.81